Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
F1000Research|April 14, 2015
Further available immunization option to prevent pneumococcal diseaseIvo Vojtek, Bernard HoetInternational Journal of Pediatric Otorhinolaryngology|August 14, 2017
Impact of pneumococcal conjugate vaccines on otitis media: A review of measurement and interpretation challengesIvo Vojtek, Marcus Nordgren, Bernard HoetVaccine|December 29, 2018
Would immunization be the same without cross-reactivity?Ivo Vojtek, Philippe Buchy, T Mark Doherty, et al.Human Vaccines & Immunotherapeutics|January 17, 2018
Stability of an aluminum salt-adjuvanted protein D-conjugated pneumococcal vaccine after exposure to subzero temperaturesJuliette Fortpied, Florence Wauters, Christelle Rochart, et al.Human Vaccines & Immunotherapeutics|August 6, 2024
Impact of COVID-19 on vaccine confidence and uptake: A systematic literature reviewIvo Vojtek, Marloes van Wouw, Angus ThomsonVaccine|May 11, 2017
Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitationsMichael Bröker, Francesco Berti, Joerg Schneider, et al.Travel Medicine and Infectious Disease|September 2, 2008
Hepatitis B immunisation in travellers: poor risk perception and inadequate protectionJane N Zuckerman, Bernard HoetHuman Vaccines & Immunotherapeutics|February 18, 2022
Evolving measles status and immunization policy development in six European countriesIvo Vojtek, Heidi Larson, Stanley Plotkin, et al.BMC Pediatrics|February 4, 2010
Do pneumococcal conjugate vaccines provide any cross-protection against serotype 19A?William P Hausdorff, Bernard Hoet, Lode SchuermanExpert Review of Vaccines|October 1, 2014
Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enoughWilliam P Hausdorff, Bernard Hoet, Richard A AdegbolaPageof 5